分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus

Miao Naijun, Wang Zhuning, Wang Qinlan, Xie Hongyan, Yang Ninghao, Wang Yanzhe, Wang Jin, Kang Haixia, Bai Wenjuan, Wang Yuanyuan, He Rui, Yan Kepeng, Wang Yang, Hu Qiongyi, Liu Zhaoyuan, Li Fubin, W

Journal:Nature Communications

IF:16.6

DOI:10.1038/s41467-023-36522-z

PMID:36797275

Published:2023-02-16

research field:癌症研究化学疗法材料科学纳米医学

Abstract

Although extracellular DNA is known to form immune complexes (ICs) with autoantibodies in systemic lupus erythematosus (SLE), the mechanisms leading to the release of DNA from cells remain poorly characterized. Here, we show that the pore-forming protein, gasdermin D (GSDMD), is required for nuclear DNA and mitochondrial DNA (mtDNA) release from neutrophils and lytic cell death following ex vivo stimulation with serum from patients with SLE and IFN-γ. Mechanistically, the activation of FcγR downregulated Serpinb1 following ex vivo stimulation with serum from patients with SLE, leading to spontaneous activation of both caspase-1/caspase-11 and cleavage of GSDMD into GSDMD-N. Furthermore, mtDNA oxidization promoted GSDMD-N oligomerization and cell death. In addition, GSDMD, but not peptidyl arginine deiminase 4 is necessary for extracellular mtDNA release from low-density granulocytes from SLE patients or healthy human neutrophils following incubation with ICs. Using the pristane-induced lupus model, we show that disease severity is significantly reduced in mice with neutrophil-specific Gsdmd deficiency or following treatment with the GSDMD inhibitor, disulfiram. Altogether, our study highlights an important role for oxidized mtDNA in inducing GSDMD oligomerization and pore formation. These findings also suggest that GSDMD might represent a possible therapeutic target in SLE.

本文使用的Yeasen产品

购物车
客服
转染试用